Cubist Systematic Strategies, LLC Xencor Inc Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Xencor Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 335,493 shares of XNCR stock, worth $5.06 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
335,493
Previous 155,580
115.64%
Holding current value
$5.06 Million
Previous $1.66 Million
59.27%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding XNCR
# of Institutions
209Shares Held
82MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$167 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.5MShares$159 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$130 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$92.6 Million4.16% of portfolio
-
State Street Corp Boston, MA3.82MShares$57.5 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $900M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...